Biomérieux Serology Tests for SARS-CoV-2 on VIDAS® Undergo Validation Preceding Imminent Launch
bioMérieux, a world leader in the field of in vitro diagnostics, today announced performance validation and the upcoming launch of VIDAS®...
Biomérieux Launches ENDOZYME® II GO, an Innovative Test for the Detection of Endotoxins in Pharmaceutical Microbiology Control
bioMérieux, a world leader in the field of industrial microbiological control, announces the launch of ENDOZYME® II GO, a new endotoxin test in...
Biomérieux Receives FDA Clearance for Expanded Pathogen Identification Capability on VITEK® MS
With more than 15,000 distinct strains, VITEK® MS provides the microbiology lab with the most comprehensive Mass Spectrometry database to...
VITEK® MS PRIME Superior Workflow Prime Results
bioMérieux S.A. • 69280 Marcy l’Étoile • France • Tel.: + 33 (0)4 78 87 20 00 • Fax: +33 (0)4 78 87 20 90 www.biomerieux.com
ULTRA-EFFICIENT...
Multiplexed Immunoassays
With a partner-first approach to the pharmaceutical industry, bioMérieux joins forces with U.S. biotechnology Company InDevR, manufacturer of...
CE Marking of Biomérieux Serology Tests for SARS-CoV-2 on VIDAS®
bioMérieux, a world leader in the field of in vitro diagnostics, today announced the CE marking of VIDAS® anti-SARS-CoV-2 serology tests to...
Sysmex and Biomérieux Agreed to Dissolve the Joint Venture Sysmex Biomérieux Co., Ltd.
Sysmex Corporation (“Sysmex”) and bioMérieux S.A. (“bioMérieux”) (Paris:BIM) announce they have agreed to transfer all of Sysmex’ holdings in...



